Cannabidiol (CBD) for Americans is different from CBD for people living in the U.K. That’s because the CBD industries within each are regulated by a completely different set of requirements. You might find a CBD product in the U.K. that seems similar to one in the U.S., but there are likely substantial differences.
CBD is one of the many different phytocannabinoids found in both the cannabis plant and industrial hemp (a variety of cannabis). Although products containing other cannabinoids like THC are governed by stricter rules, it’s fully legal to produce and sell CBD products in both the U.S. and the U.K. You don’t even have to find a certified dispensary—CBD products can be ordered online or found just about anywhere, from gas stations to grocery stores.
The similarities between the nations’ markets end there, though. In fact, the differences between CBD products sold in the U.K. and CBD products sold in the U.S. are so major that most of the CBD products sold in the U.S. could not be sold in the U.K. Let’s take a closer look.
The legal CBD industry in the U.K. is relatively new. It took some time for regulators to nail down specifics, such as the accepted percentage of THC allowed in hemp products and whether or not full-spectrum products would be allowed. When it comes to CBD products in the U.K., there are very stringent guidelines to adhere to, especially if a company wants to remain compliant with the Cannabis Trades Association (CTA).
All CBD products sold in the U.K. must contain no more than 1mg of THC. They must also only come from European Union (EU)-approved hemp cultivars. To implement these strict regulations, all CBD products imported to the U.K. undergo multiple independent lab tests. The results of these tests are always made accessible to retailers and consumers as well as any government agencies requesting them. In the U.S., CBD products do not have the same testing requirements as those in the U.K.
The U.K. is no less strict when it comes to talking about CBD. In the U.S., CBD businesses are allowed to cite medical research found in reputable journals such as The Journal of the American Medical Association (JAMA). As long as it’s made clear that CBD is not FDA-approved, they can talk about how CBD makes people feel and how it can help with pain, depression, anxiety, insomnia, etc. In the U.K., none of this is allowed if a company wants to stay compliant with regulatory authorities like the CTA.
In contrast to the U.S., U.K. CBD companies are not permitted to make any medical claims regarding the cannabinoid. This applies to websites and social media in addition to labels and advertisements. Companies cannot cite research that supports CBD’s therapeutic attributes; instead, they can only suggest it as a smart lifestyle decision and encourage consumers to do their own research. While companies can and have tried throwing out wild claims, they generally have to answer to the FSA (Food Standards Agency) and CTA. As a result, CBD brands in the U.K. are finding the most success via word-of-mouth advertising.
The U.K. CBD market is one of the largest in Europe. In 2019 the legal CBD industry in the U.K. was worth an estimated £300 million ($347,996,353.00 USD). Today in 2021, that number has expanded to achieve an impressive £630 million ($730,792,341.30 USD), and projections put it on track to achieve the £1 billion ($1,159,987,843.33 USD) mark by as early as 2025.
The legal CBD industry in the U.S. is even bigger. Current projections issued by Statista place the U.S. CBD industry on track to reach an estimated value of around $23 billion dollars by as early as 2025. In 2019 California was the biggest consumer market for CBD in America, raking in $730 million dollars in CBD sales. To put this in perspective, California’s 2019 CBD sales surpassed 2021 CBD sales in the entire U.K.
The U.K.’s CBD market is on the rise, but a serious barrier still stands in the way: hemp cultivation. Hemp farmers and processors in the U.K. are practically non-existent since it is not profitable to work in the sector yet. For those who have taken the plunge into the industry, tight regulations on what can and can’t be used (stalks, leaves, buds, seeds) make cultivation difficult. Thus, the majority of industrial hemp products brought into the U.K. currently come from the U.S.
Nonetheless, CBD products appear to be a hit in the U.K. and won’t be going anywhere anytime soon. It may take some time to work out the kinks in the system, but the U.K. CBD industry is sure to catch up to the U.S. in no time.
It’s safe to say that the wheels on the cannabis reform express have certainly been set in motion. As of April 2022, 47 states have legalized cannabis in some form or another. However, the plant’s federally illegal status—U.S. law categorizes cannabis as a Schedule I drug—means that businesses operating in this industry cannot conduct transactions with…
Cannabis’ former reputation as a gateway drug may have been dispelled, but it turns out that there is some element of truth to the rumor: The plant’s progressively evolving status as a normalized medicine in 37 U.S. states and a recreational substance in 18 U.S. states is prompting a wave of change across America’s statehouses….
Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. Nicknamed “K,” “special K,” “cat valium,” and “vitamin K,” ketamine is…
Austin decriminalized cannabis possession, Vancouver is now home to some not-so-legal magic mushroom shops, and a British woman shared her life-changing medical marijuana journey. Let’s dive into this week’s cannanews. Austin Voters Pass Cannabis Decriminalization Bill Voters in Austin, Texas, have approved Proposition A, a ballot measure that decriminalizes cannabis possession and bans no-knock warrants….
Have you ever wondered whether one can be allergic to cannabis? Some may laugh at the suggestion of one being allergic to cannabis considering its widely known safety and efficacy. However, like most substances, there may be some individuals who are allergic to it. According to the Asthma and Allergy Foundation of America, more than…
The worldwide skincare industry, which is projected to inflate to $189.3 billion USD by 2025, could soon be merging more closely with…
Woody Harrelson’s new dispensary opened for business, Thailand announced its giveaway of 1 million cannabis plants, and Vermont awarded its first cannabis…
There’s no denying the fact that CBD is dominating the wellness landscape. Increasing awareness of the cannabinoid’s medicinal effects is going hand-in-hand…